Distillate Capital Partners LLC has filed its 13F form on May 13, 2025 for Q1 2025 where it was disclosed a total value porftolio of $1.84 Billion distributed in 119 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Unitedhealth Group Inc with a value of $69M, Merck & Co., Inc. with a value of $56M, Abb Vie Inc. with a value of $53.1M, Johnson & Johnson with a value of $46.8M, and Procter & Gamble CO with a value of $41.3M.

Examining the 13F form we can see an decrease of $156M in the current position value, from $1.99B to 1.84B.

Below you can find more details about Distillate Capital Partners LLC portfolio as well as his latest detailed transactions.

Portfolio value $1.84 Billion
Healthcare: $474 Million
Technology: $313 Million
Industrials: $287 Million
Consumer Cyclical: $240 Million
Energy: $142 Million
Consumer Defensive: $136 Million
Communication Services: $112 Million
Financial Services: $60.4 Million
Other: $73.7 Million

Stock Holdings Table Market Cap. of $300 Millions to $2 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 119
  • Current Value $1.84 Billion
  • Prior Value $1.99 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 13, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 22 stocks
  • Additional Purchases 11 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 82 stocks
Track This Portfolio

Track Distillate Capital Partners LLC Portfolio

Follow Distillate Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Distillate Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Distillate Capital Partners LLC with notifications on news.